This is a news story, published by CNBC, that relates primarily to FDA news.
For more drug discoveries news, you can click here:
more drug discoveries newsFor more news from CNBC, you can click here:
more news from CNBCOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
oral phenylephrine. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest nasal decongestant news, phenylephrine news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
phenylephrine productsCNBC
•
87% Informative
The FDA said an extensive review of available data determined that the ingredient, oral phenylephrine, doesn't actually relieve nasal congestion.
A final decision would force pharmacies to clear shelves of hundreds of products containing oral forms of the ingredient.
The FDA could revoke the drug's over-the-counter designation as "generally recognized as safe and effective".
VR Score
87
Informative language
86
Neutral language
76
Article tone
formal
Language
English
Language complexity
69
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
3
Source diversity
3
Affiliate links
no affiliate links